» Articles » PMID: 33343496

Higher Cho/NAA Ratio in Postoperative Peritumoral Edema Zone Is Associated With Earlier Recurrence of Glioblastoma

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Dec 21
PMID 33343496
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the prognostic significance of metabolic parameters in postoperative peritumoral edema zone (PEZ) of patients with glioblastoma (GBM) based on proton magnetic resonance spectroscopy (MRS). The postoperative MRS data of 67 patients with GBM from Beijing Tiantan Hospital were retrospectively reviewed. Metabolite ratios including Cho/NAA, Cho/Cr, and NAA/Cr in both postoperative PEZ and contralateral normal brain region were recorded. Log-rank analysis and Cox regression model were used to identify parameters correlated with progression-free survival (PFS) and overall survival (OS). Compared with the contralateral normal brain region, postoperative PEZ showed a lower ratio of NAA/Cr (1.20 ± 0.42 vs. 1.81 ± 0.48, < 0.001), and higher ratios of Cho/Cr and Cho/NAA (1.36 ± 0.44 vs. 1.02 ± 0.27, < 0.001 and 1.32 ± 0.59 vs. 0.57 ± 0.14, < 0.001). Both the ratios of Cho/NAA and NAA/Cr were identified as prognostic factors in univariate analysis ( < 0.05), while only Cho/NAA ≥ 1.31 was further confirmed as an independent risk factor for early recurrence in the Cox regression model ( < 0.01). According to the factors of MGMT promoter unmethylation, without radiotherapy and Cho/NAA ≥ 1.31, a prognostic scoring scale for GBM was established, which could divide patients into low-risk, moderate-risk, and high-risk groups. There was a significant difference of survival rate between the three groups ( < 0.001). Higher Cho/NAA ratio in the postoperative PEZ of GBM predicts earlier recurrence and is associated with poor prognosis. The prognostic scoring scale based on clinical, molecular and metabolic parameters of patients with GBM can help doctors to make more precise prediction of survival time and to adjust therapeutic regimens.

Citing Articles

Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.

Rossi J, Zedde M, Napoli M, Pascarella R, Pisanello A, Biagini G Life (Basel). 2025; 14(12.

PMID: 39768232 PMC: 11677825. DOI: 10.3390/life14121523.


Turning attention to tumor-host interface and focus on the peritumoral heterogeneity of glioblastoma.

Wang F, Dong J, Xu Y, Jin J, Xu Y, Yan X Nat Commun. 2024; 15(1):10885.

PMID: 39738017 PMC: 11685534. DOI: 10.1038/s41467-024-55243-5.


Multimodal MRI and H-MRS for Preoperative Stratification of High-Risk Molecular Subtype in Adult-Type Diffuse Gliomas.

Han X, Xiao K, Bai J, Li F, Cui B, Cheng Y Diagnostics (Basel). 2024; 14(22).

PMID: 39594235 PMC: 11592885. DOI: 10.3390/diagnostics14222569.


Peritumoral Brain Zone in Astrocytoma: Morphology, Molecular Aspects, and Clinical Manifestations (Review).

Grishin A, Achkasova K, Kukhnina L, Sharova V, Ostapyuk M, Yashin K Sovrem Tekhnologii Med. 2024; 16(2):79-88.

PMID: 39539752 PMC: 11556047. DOI: 10.17691/stm2024.16.2.08.


Improved Recovery of Complete Spinal Cord Transection by a Plasma-Modified Fibrillar Scaffold.

Osorio-Londono D, Heras-Romero Y, Tovar-y-Romo L, Olayo-Gonzalez R, Morales-Guadarrama A Polymers (Basel). 2024; 16(8).

PMID: 38675052 PMC: 11054293. DOI: 10.3390/polym16081133.


References
1.
Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L . 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys. 2002; 52(5):1271-6. DOI: 10.1016/s0360-3016(01)02769-9. View

2.
Jiang H, Cui Y, Liu X, Ren X, Li M, Lin S . Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region. J Neurosurg. 2019; 132(4):998-1005. DOI: 10.3171/2018.12.JNS182775. View

3.
Guo J, Yao C, Chen H, Zhuang D, Tang W, Ren G . The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien). 2012; 154(8):1361-70. PMC: 3407558. DOI: 10.1007/s00701-012-1418-x. View

4.
Wu C, Lin G, Lin Z, Zhang J, Chen L, Liu S . Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma. Oncol Lett. 2016; 10(5):2769-2776. PMC: 4665258. DOI: 10.3892/ol.2015.3639. View

5.
Cordova J, Shu H, Liang Z, Gurbani S, Cooper L, Holder C . Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients. Neuro Oncol. 2016; 18(8):1180-9. PMC: 4933486. DOI: 10.1093/neuonc/now036. View